We believe that the mouse anti-human bFGF/VEGFA antibodies elicited by Peptibody can neutralize the dissociative murine bFGF/VEGFA in tumor microenvironment (TME) and the pathways related in the tumor cells will be down-regulated, resulting in tumorigenesis and angiogenesis inhibition. The gene discussed is VEGFA; the disease is neoplasm.